Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Copeland

Showing results (121-130 of 125) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 125 results.
Molecular Genetics and Metabolism|February 28, 2012
Iminosugar-based inhibitors of glucosylceramide synthase prolong survival but paradoxically increase brain glucosylceramide levels in Niemann-Pick C miceJennifer B Nietupski, Joshua J Pacheco, Wei-Lien Chuang, et al.
Plos One|July 9, 2011
Iminosugar-based inhibitors of glucosylceramide synthase increase brain glycosphingolipids and survival in a mouse model of Sandhoff diseaseKaren M Ashe, Dinesh Bangari, Lingyun Li, et al.
Radiology|November 7, 2018
A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using <sup>18</sup>F-FDG PET of the BrainYiming Ding, Jae Ho Sohn, Michael G Kawczynski, et al.
International Journal of Oncology|December 28, 2010
The chemosensitizing activity of inhibitors of glucosylceramide synthase is mediated primarily through modulation of P-gp functionLilly Chai, Rajashree P McLaren, Ann Byrne, et al.
Scientific Reports|November 15, 2024
Genetic connectivity of wolverines in western North AmericaCasey C Day, Erin L Landguth, Michael A Sawaya, et al.
Pageof 13

Showing results (121-130 of 125) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 125 results.
Molecular Genetics and Metabolism|February 28, 2012
Iminosugar-based inhibitors of glucosylceramide synthase prolong survival but paradoxically increase brain glucosylceramide levels in Niemann-Pick C miceJennifer B Nietupski, Joshua J Pacheco, Wei-Lien Chuang, et al.
Plos One|July 9, 2011
Iminosugar-based inhibitors of glucosylceramide synthase increase brain glycosphingolipids and survival in a mouse model of Sandhoff diseaseKaren M Ashe, Dinesh Bangari, Lingyun Li, et al.
Radiology|November 7, 2018
A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using <sup>18</sup>F-FDG PET of the BrainYiming Ding, Jae Ho Sohn, Michael G Kawczynski, et al.
International Journal of Oncology|December 28, 2010
The chemosensitizing activity of inhibitors of glucosylceramide synthase is mediated primarily through modulation of P-gp functionLilly Chai, Rajashree P McLaren, Ann Byrne, et al.
Scientific Reports|November 15, 2024
Genetic connectivity of wolverines in western North AmericaCasey C Day, Erin L Landguth, Michael A Sawaya, et al.
Pageof 13